Acromegaly with No Evidence of Pituitary Adenoma or Ectopic Source
Endocrinology Research and Practice · 2017
DOI: 10.25179/tjem.2017-56489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology Research and Practice, 2017. Verfasst von Işılay KALAN SARI und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Acromegaly is caused by the uncontrolled hypersecretion of growth hormone (GH) and secondary increases of insulin-like growth factor–1. More than 95% of patients with acromegaly have a growth hormone-secreting pituitary adenoma. Ectopic GH or growth hormone releasing hormone (GHRH)-secreting tumors are rare cause of acromegaly. Pituitary adenomas that cause the hypersecretion of GH are nearly always visible on magnetic resonance imaging. Rarely, patients without an ectopic source may have normal pituitary imaging. In managing this rare circumstance, exploring pituitary or medical treatment with a somatostatin analog might be useful. We describe a patient with acromegaly with no pituitary adenoma and no evidence of ectopic source, who was treated with long-acting octreotide.
Zitieren
APA
SARI, I. K., DEMİRCİ, H., & DURMAZ, Ş. A. (2017). Acromegaly with No Evidence of Pituitary Adenoma or Ectopic Source. Endocrinology Research and Practice. https://doi.org/10.25179/tjem.2017-56489
Vancouver
SARI IK, DEMİRCİ H, DURMAZ ŞA. Acromegaly with No Evidence of Pituitary Adenoma or Ectopic Source. Endocrinology Research and Practice. 2017. doi:10.25179/tjem.2017-56489
BibTeX
@article{SARI2017,
author = {SARI, Işılay KALAN and DEMİRCİ, Hüseyin and DURMAZ, Şenay ARIKAN},
title = {Acromegaly with No Evidence of Pituitary Adenoma or Ectopic Source},
journal = {Endocrinology Research and Practice},
year = {2017},
doi = {10.25179/tjem.2017-56489}
}
EUVIMED